Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;73(3):962-965.
doi: 10.1007/s43440-021-00231-5. Epub 2021 Feb 18.

Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2

Albert Cortés-Borra  1 , Gonzalo Emiliano Aranda-Abreu  2
Affiliations

Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2

Albert Cortés-Borra et al. Pharmacol Rep. 2021 Jun.

Abstract

Background: Amantadine is a drug that can help in the prevention of SARS-CoV-2 symptomatology, as has been demonstrated in observational clinical studies.

Methods: We searched in the PubMed database Clinical Studies of coronavirus-infected patients who have been treated with amantadine in a preventive manner as well as patients with Parkinson's disease.

Results: Four clinical studies were found in which relatives of patients with COVID-19 had been prescribed the use of amantadine in a preventive manner to avoid the symptoms caused by the coronavirus.

Conclusion: Amantadine is a drug that can be prescribed as a prophylactic that prevents symptomatology caused by SARS-CoV-2 coronavirus.

Keywords: Amantadine; Prevention; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

No conflict of interest.

References

    1. Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta bio-medica: AteneiParmensis. 2020;91(1):157–160. - PMC - PubMed
    1. RECOVERY CG, Horby P, Mafham M, Linsell L, Bell JL, Staplin N. EffEnect of Hydroxychloroquine in Hospitalized Patients with Covid-19. N Engl J Med. 2020;383(21):2030–2040. doi: 10.1056/NEJMoa2022926. - DOI - PMC - PubMed
    1. Sharun K, Dhama K, Patel SK, Pathak M, Tiwari R, Singh BR, et al. Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19. Ann ClinMicrobiolAntimicrob. 2020;19(1):23. - PMC - PubMed
    1. Ledford H. Coronavirus breakthrough: dexamethasone is first drug shown to save lives. Nature. 2020;582(7813):469. doi: 10.1038/d41586-020-01824-5. - DOI - PubMed
    1. Choi SW, Shin JS, Park SJ, Jung E, Park YG, Lee J. et al., Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes. Antiviral Res. 2020; p. 104955. - PMC - PubMed

LinkOut - more resources